Pam Bondi is the former U.S. Attorney General who was recently removed from her position by President Donald Trump in early April, and it was just revealed that she has been quietly battling thyroid cancer. Following her departure from the Justice Department—where she faced scrutiny over her handling of the Jeffrey Epstein files and was replaced by acting Attorney General Todd Blanche. As per several media reports, the 60-year-old Bondi underwent surgery and is better and recovering. Here’s all you need to know about this rare cancer, risk associated and symptoms. Read on to find out…
Pam Bondi with US President Donald Trump (file photo)
The roles and resignationsThe former attorney general, Pam Bondi, recently took to social media to share her progress and health condition. Bondi said she was “doing well” after undergoing surgery for thyroid cancer. In an interview with CNN, Bondi expressed that the diagnosis came shortly after she left the Justice Department in early April. President Donald Trump replaced Bondi as attorney general, with Todd Blanche currently serving as acting attorney general. As per reports, Bondi’s diagnosis is alongside her new role on the Presidential Council of Advisors on Science and Technology.Understanding Thyroid CancerThe thyroid is a small, butterfly-shaped gland that is situated at the base of the neck. As a core part of the endocrine system, it regulates the body’s metabolism and helps in converting food into energy and controls vital functions like heart rate, body temperature, digestion, and breathing.Risk FactorsThyroid cancer is relatively uncommon, with roughly 45,240 cases expected in 2026. However, women are diagnosed at a rate nearly three times higher than men, a disparity largely attributed to hormonal factors. Here are some of the reasons that increase the risk of this cancer.Age: It most frequently impacts individuals between their 30s and 60s.Preexisting Conditions: Diseases like Hashimoto’s thyroiditis increase risk.Lifestyle & Genetics: Excess body weight, radiation exposure, and family history play major roles.Types of Thyroid CancerWhen it comes to the severity of this cancer, it depends heavily on the specific cell type:Papillary: This is the common kind of thyroid cancer making up about 90% of cases. Thyroid cancer of this type grows slowly gets better with treatment and’s rarely deadly.Follicular: More aggressive than papillary and more likely to spread to bones and internal organs.Oncocytic: A rare variation making up 3% to 5% of cases; it is notably harder to treat.Medullary: Makes up less than 5% of cases. It is often hereditary, with a quarter of cases tied to an inherited condition called multiple endocrine neoplasia type 2.Anaplastic: The rarest and most aggressive form. It spreads rapidly into surrounding tissue and is exceptionally difficult to treat.Signs and SymptomsCancer has always been the silent killer, but most thyroid cancers do not present any early symptoms. When symptoms occur, the most common sign is a painless lump in the neck, known as a thyroid nodule. Patients may also experience neck swelling, hoarseness in their voice, or difficulty breathing and swallowing. But is there any possible treatment? Let’s find out…TreatmentAccording to the experts, the prognosis for thyroid cancer is generally highly optimistic. The most common forms—papillary and follicular—boast a five-year survival rate of over 98%. On the contrary, the highly aggressive anaplastic thyroid cancer has a standard survival rate of just five to six months post-diagnosis. Surgery is the primary treatment method used to remove either the damaged sections or the entirety of the thyroid gland. If the entire gland is removed, patients must rely on daily hormone replacement medication for the rest of their lives. However, as per experts, to eliminate any lingering cancer cells after surgery, doctors frequently utilize radioactive iodine therapy, administered via a pill or liquid. In rare instances where advanced or aggressive cancers do not respond to radiation, chemotherapy may be required.